Abstract
The use of HBO has been investigated in a number of diseases such as cerebral palsy and multiple sclerosis. Uncontrolled publications with weak levels of evidence have sometimes suggested a positive effect of HBO. However, thoroughly done RCT did not show any effect on the course of diseases or such studies have not been performed. It must be considered that HBO has no effect and can only be deleterious in these conditions
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Montgomery D, Goldberg J, Amar M, et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperb Med 1999; 26:235–242.
Collet JP, Vanasse M, Marois P, Amar M, Goldberg J, Lambert J, Lassonde M, Hardy P, Fortin J, Tremblay SD, Montgomery D, Lacroix J, Robinson A, Majnemer A. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP Research Group. Lancet. 2001 Feb 4; 357:582–6.
Fischer BH, Marks M, Reich T. Hyperbaric-oxygen treatment of multiple sclerosis. A randomized, placebo-controlled, double-blind study. N Engl J Med. 1983 Jan 27; 308: 181–6.
Kleijnen J, Knipschild P. Hyperbaric oxygen for multiple sclerosis. Review of controlled trials. Acta Neurol Scand. 1995 May; 91:330–4.
Bennett M, Heard R. Hyperbaric oxygen therapy for multiple sclerosis.: Cochrane Database Syst Rev. 2004:CD003057.
Kindwall EP, McQuillen MP, Khatri BO, Gruchow HW, Kindwall ML. Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry. Arch Neurol. 1991 Feb;48:195–9.
Gilden DH. Clinical practice. Bell’s palsy. N Engl J Med. 2004 Sep 23; 351:1323–31.
Racic G, Denoble PJ, Sprem N, Bojic L, Bota B. Hyperbaric oxygen as a therapy of Bell’s palsy. Undersea Hyperb Med. 1997; 24:35–8.
Schwartz DA, Herdman CR. Review article: The medical treatment of Crohn’s perianal fistulas. Aliment Pharmacol Ther. 2004 May 1; 19:953–67.
Ardizzone S, Maconi G, Colombo E, Manzionna G, Bollani S, Porro GB. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis. 2004 Mar;10:91–6.
Colombel JF, Mathieu D, Bouault JM, Lesage X, Zavadil P, Quandalle P, Cortot A. Hyperbaric oxygenation in severe perineal Crohn’s disease. Dis Colon Rectum. 1995 Jun; 38:609–14.
Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn’s disease. J Clin Gastroenterol. 1994 Oct; 19:202–5.
Lamm K, Lamm H, and Arnold W: Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus: A literature survey; in Yanagita N, Nakashima (eds): Hyperbaric Oxygen Therapy in Otorhinolaryngology. Adv Otorhinolaryngol. Basel, Karger, 1998, vol 54, pp 86–99.
Bohmer D. Treating Tinnitus with Hyperbaric Oxygenation. Int Tinnitus J. 1997; 3:137–140.
Schumann K, Lamm K, Hettich M. Effect and effectiveness of hyperbaric oxygen therapy in chronic hearing disorders. Report of 557 cases 1989. HNO. 1990 Nov;38:408–11.
Delb W, Muth CM, Hoppe U, Iro H. Outcome of hyperbaric oxygen therapy in therapy refractory tinnitus HNO. 1999 Dec; 47:1038–45.
Tan J, Tange RA, Dreschler WA, vd Kleij A, Tromp EC Long-term effect of hyperbaric oxygenation treatment on chronic distressing tinnitus. Scand Audiol. 1999; 28:91–6.
Kau RJ, Sendtner-Gress K, Ganzer U, Arnold W. Effectiveness of hyperbaric oxygen therapy in patients with acute and chronic cochlear disorders. ORL J Otorhinolaryngol Relat Spec. 1997 Mar–Apr; 59:79–83.
Van Ophoven A, Rossbach G, Oberpenning F, Hertle L. Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study. Eur Urol. 2004 Jul; 46:108–13.
Verin P, Comte P, Poisot D. Retinitis pigmentosa and hyperbaric oxygen therapy. Bull Soc Ophtalmol Fr. 1986 Aug–Sep; 86:1071–2
Vingolo EM, P. Pelaia, R. Forte, M. Rocco, C. Giusti, E. Rispoli. Does HBO delivery rescue retinal photoreceptors in retinitis pigmentosa?. Documentia Ophtalmologica. 1999, 97: 33–9.
Jacobson L., Harper A.M., Mc Dowall DG. The effect of oxygen under pressure on cerebral blood flow and cerebral venous tension. Lancet, 1963, 2: 549.
Myers DE, Myers RA. A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache. 1995 Apr; 35:197–9.
Wilson JR, Foresman BH, Gamber RG, Wright T. Hyperbaric oxygen in the treatment of migraine with aura. Headache. 1998 Feb; 38:112–5.
Eftedal OS, Lydersen S, Helde G, White L, Brubakk AO, Stovner LJ. A randomized, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia. 2004 Aug;24:639–44.
Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large doubleblind placebo-controlled trial.
Borromeo CN, Ryan JL, Marchetto PA, Peterson R, Bove AA. Hyperbaric oxygen therapy for acute ankle sprains. Am J Sports Med. 1997 Sep–Oct;25:619–25.
Staples JR, Clement DB, Taunton JE, McKenzie DC. Effects of hyperbaric oxygen on a human model of injury. Am J Sports Med. 1999 Sep–Oct;27:600–5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Schmutz, J. (2006). Other Controversial or Non Indications. In: Mathieu, D. (eds) Handbook on Hyperbaric Medicine. Springer, Dordrecht. https://doi.org/10.1007/1-4020-4448-8_37
Download citation
DOI: https://doi.org/10.1007/1-4020-4448-8_37
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-4376-5
Online ISBN: 978-1-4020-4448-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)